BridgeBio Pharma (NASDAQ:BBIO) Shares Up 10.2% on Earnings Beat
BridgeBio Pharma (NASDAQ:BBIO) traded up 10.2% on Thursday following a better than expected earnings announcement. The company traded as high as $25.43 and last traded at $24.42, 237,792 shares were traded during trading. A decline of 15% from the average session volume of 279,227 shares. The stock had previously closed at $22.16.
The company reported ($0.51) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.55) by $0.04. The business had revenue of $26.74 million during the quarter.
A number of analysts have weighed in on the company. Jefferies Financial Group assumed coverage on BridgeBio Pharma in a research note on Monday, July 22nd. They issued a “buy” rating and a $38.00 target price on the stock. Zacks Investment Research lowered BridgeBio Pharma ...